Product category:
Clinical chemistry analysis
News Release from: Siemens Healthcare Diagnostics | Subject: cPSA assay
Edited by the Laboratorytalk Editorial
Team on 31 October 2003
Experts endorse efficacy of prostate
cancer assay
Clinical evaluations to show that the cPSA test is 7%-22% more specific for prostate cancer than traditional detection tools such as total PSA, leading to fewer false positive results
A lunchtime seminar on the role of complexed prostate specific antigen (cPSA) testing in prostate cancer risk management was hosted by Bayer Diagnostics at the 2003 meeting of the International Society for Oncodevelopmental Biology and Medicine (ISOBM) Bernard Croal, clinical senior lecturer in health services research and consultant in clinical biochemistry at Grampian University Hospitals Trust, addressed delegates on the clinical and financial efficacy of the cPSA assay which is available for Bayer's automated immunoassay systems
This article was originally published on Laboratorytalk on 29 Apr 2004 at 8.00am (UK)
Related stories
Better prediction of prostate cancer
Major study shows complexed prostate specific antigen (cPSA) to be more predictive of prostate cancer than total PSA, resulting in fewer false diagnoses and unnecessary biopsies
He presented study results indicating that use of the assay can lead to a reduction in the number of men undergoing unnecessary prostatic biopsies, thus optimising diagnostic cost-effectiveness.
Rainer Neumann of Bayer's European scientific affairs department cited several other clinical evaluations to show that the Bayer cPSA test is 7%-22% more specific for prostate cancer than traditional detection tools such as total PSA, leading to fewer false positive results.
This has since been confirmed by a major study on the detection of prostate cancer published in the Journal of Urology, November 20031.
• Siemens Healthcare Diagnostics: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

